Cheryl Willman
Overview
Explore the profile of Cheryl Willman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
1030
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chang T, Chen W, Qu C, Cheng Z, Elsayed A, Pounds S, et al.
J Clin Oncol
. 2024 Dec;
43(8):1039-1041.
PMID: 39715469
No abstract available.
2.
Chang T, Chen W, Qu C, Cheng Z, Hedges D, Elsayed A, et al.
J Clin Oncol
. 2024 Aug;
42(29):3491-3503.
PMID: 39121442
Purpose: Although cure rates for childhood acute lymphoblastic leukemia (ALL) exceed 90%, ALL remains a leading cause of cancer death in children. Half of relapses arise in children initially classified...
3.
Schuster A, Crossnohere N, Bachini M, Blair C, Carpten J, Claus E, et al.
Cancer Epidemiol Biomarkers Prev
. 2023 Feb;
32(4):487-495.
PMID: 36791345
Background: Engaging diverse populations in cancer genomics research is of critical importance and is a fundamental goal of the NCI Participant Engagement and Cancer Genome Sequencing (PE-CGS) Network. Established as...
4.
Cole K, Varela S, Rumalla K, Kazim S, Rebbe R, Carvajal M, et al.
Surg Neurol Int
. 2022 Nov;
13:404.
PMID: 36324951
Background: The awake craniotomy (AC) procedure allows for safe and maximal resection of brain tumors from highly eloquent regions. However, geriatric patients are often viewed as poor candidates for AC...
5.
Safi S, Ghahate D, Bobelu J, Sussman A, Rodman J, Wandinger-Ness A, et al.
J Cancer Educ
. 2021 May;
37(6):1752-1759.
PMID: 33963443
American Indians (AIs) in New Mexico have lower cancer screening rates compared to other populations and are more likely to be diagnosed with cancer at an advanced stage of the...
6.
Knudsen K, Willman C, Winn R
Clin Cancer Res
. 2020 Nov;
27(4):933-936.
PMID: 33229457
Utilization of telehealth as part of the cancer care delivery continuum dramatically escalated in response to the COVID-19 pandemic at major cancer centers across the globe. The rapid shift toward...
7.
Saint Fleur-Lominy S, Evensen N, Bhatla T, Sethia G, Narang S, Choi J, et al.
Cancer Res
. 2020 Oct;
80(23):5189-5202.
PMID: 33067268
Although B-cell acute lymphoblastic leukemia (B-ALL) is the most common malignancy in children and while highly curable, it remains a leading cause of cancer-related mortality. The outgrowth of tumor subclones...
8.
Winick N, Martin P, Devidas M, Shuster J, Borowitz M, Bowman W, et al.
Leukemia
. 2019 Nov;
34(4):1006-1016.
PMID: 31728054
The delayed intensification (DI) enhanced outcome for patients with acute lymphoblastic leukemia (ALL) treated on BFM 76/79 and CCG 105 after a prednisone-based induction. Childrens Oncology Group protocols P9904/9905 evaluated...
9.
Winick N, Devidas M, Chen S, Maloney K, Larsen E, Mattano L, et al.
J Clin Oncol
. 2017 May;
35(22):2527-2534.
PMID: 28535084
Purpose To determine the prognostic significance of blasts, and of white and red blood cells, in CSF samples at diagnosis of acute lymphoblastic leukemia (ALL), a uniform CSF and risk...
10.
Advani A, McDonough S, Copelan E, Willman C, Mulford D, List A, et al.
Br J Haematol
. 2014 Jul;
167(2):233-7.
PMID: 25039477
Inhibition of cholesterol synthesis and uptake sensitizes acute myeloid leukaemia (AML) blasts to chemotherapy. A Phase 1 study demonstrated the safety of high dose pravastatin given with idarubicin and cytarabine...